Effectiveness of Outpatient Intravenous Diuretic Therapy for Treatment of Worsening Heart Failure (OUTPATIENT-WHF)

Duke University logo

Duke University

Status

Enrolling

Conditions

Heart Failure

Treatments

Other: Initial outpatient management strategy, including outpatient IV diuretics in clinic
Other: Initial hospitalization-based management strategy

Study type

Interventional

Funder types

Other

Identifiers

NCT05704595
Pro00111091

Details and patient eligibility

About

The purpose of the OUTPATIENT-WHF study is to characterize the effectiveness of outpatient intravenous diuretic therapy as a treatment for worsening heart failure.

Full description

The purpose of this study is to determine whether treating certain patients with worsening heart failure as an outpatient with intravenous and oral medications can work just as well as treating patients in the hospital. Participants who enter into the study and meet eligibility criteria will be randomly chosen to either get intravenous diuretic like Lasix in the clinic and get outpatient care, versus directly admitted to the hospital to receive intravenous diuretic and normal hospital care.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years of age
  • Presentation to a Duke outpatient clinic with heart failure requiring IV diuretics, as per clinician judgement
  • Able to provide signed informed consent
  • Successful completion of EuroQOL-5 dimensions survey

Exclusion criteria

  • Managing clinician without equipoise for initial outpatient treatment strategy versus initial hospitalization-based treatment strategy for heart failure, and decline to accept randomization.
  • Patient without equipoise for initial outpatient treatment strategy versus initial hospitalization-based treatment strategy for heart failure, and decline to accept randomization.
  • History of left ventricular assist device or heart transplantation
  • End-stage kidney disease requiring chronic dialysis therapy
  • New diagnosis of heart failure
  • Pregnant or breast-feeding
  • Fever >101.0 degrees Fahrenheit at screening
  • Any other condition that in the judgment of the investigator would jeopardize the patient's compliance with the study protocol

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Initial outpatient management strategy, including outpatient IV diuretics in clinic
Other group
Treatment:
Other: Initial outpatient management strategy, including outpatient IV diuretics in clinic
Initial hospitalization-based management strategy
Other group
Treatment:
Other: Initial hospitalization-based management strategy

Trial contacts and locations

0

Loading...

Central trial contact

Stephen Greene

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems